181 results on '"Lièvre, Michel"'
Search Results
2. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
3. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
4. Baseline characteristics and outcomes after transcatheter aortic-valve implantation in patients with or without previous balloon aortic valvuloplasty: Insights from the FRANCE 2 registry
5. Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: Results From the FRANCE-2 Registry
6. Comparison of Outcome of Transcatheter Aortic Valve Implantation With Versus Without Previous Coronary Artery Bypass Grafting (from the FRANCE 2 Registry)
7. Comparison of Outcomes After One-Versus-Two Transcatheter Aortic Valve Implantation During a Same Procedure (from the FRANCE2 Registry)
8. Evaluation of a mobile electronic assistant to aid in fluindione prescription: The INRPlus cluster randomized trial
9. Impact of Chronic Obstructive Pulmonary Disease on Valve Academic Research Consortium–Defined Outcomes After Transcatheter Aortic Valve Implantation (from the FRANCE 2 Registry)
10. Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients: FRANCE-2 Registry
11. Clinical Results of Transcatheter Aortic Valve Implantation in Octogenarians and Nonagenarians: Insights From the FRANCE-2 Registry
12. Effect of Body Mass Index on 30- and 365-Day Complication and Survival Rates of Transcatheter Aortic Valve Implantation (from the FRench Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry)
13. How can the Quality of Medical Data in Pharmacovigilance, Pharmacoepidemiology and Clinical Studies be Guaranteed?
14. Comment garantir des données médicales de qualité dans les études cliniques, pharmaco-épidémiologiques et en pharmacovigilance ?
15. Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial
16. Place des études post-AMM dans le suivi des risques du médicament : cahier des charges et méthodologies
17. Role of the Post-Marketing Authorisation Studies in Drug Risk Surveillance: Specifications and Methodologies
18. Additional file 1 of A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radioresistant tumors: the ETOILE trial
19. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)
20. Définition des populations cibles des médicaments : comment anticiper au mieux la définition des populations cibles en vue du remboursement ?
21. How to Best Define Target Populations of Medicines in View of Their Coverage by the National Health Insurance Scheme?
22. Alosetron For Irritable Bowel Syndrome: Some Patients May Pay A High Price For The Fda's Decision To Put The Drug Back On The Market
23. Medicalisation: Peering From Inside Medicine: Professionals And Lay People Should Work Together To A Common Purpose
24. Premature Discontinuation Of Clinical Trial For Reasons Not Related To Efficacy, Safety, Or Feasibility
25. Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry)
26. Bénéfice médical réel estimé par comparaisons indirectes
27. Real Medical Benefit Assessed by Indirect Comparison
28. Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy
29. New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linear
30. Long-Term Follow-Up Study of Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis Trial
31. Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score
32. High Post-Procedural Transvalvular Gradient or Delayed Mean Gradient Increase after Transcatheter Aortic Valve Implantation: Incidence, Prognosis and Associated Variables. The FRANCE-2 Registry
33. Evaluation of adverse treatment effects in controlled trials
34. Évaluation du risque thérapeutique au cours des essais contrôlés
35. Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis
36. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET
37. Validation of a new quantitative coronary angiography analysis system used to evaluate densitometric lumen remodelling
38. Assessment of Patientsʼ and Physiciansʼ Compliance to an ACE Inhibitor Treatment Based on Urinary N-Acetyl Ser-Asp-Lys-Pro Determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) Study
39. Anemia treatment and decline of renal function
40. Short-Term Efficacy and Safety of Extended-Release Fluvastatin in a Large Cohort of Elderly Patients
41. Les stratégies thérapeutiques médicamenteuses et non médicamenteuses de l’aide à l’arrêt du tabac
42. <scp>close</scp>: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study design
43. Determinants of Elevated Urinary Albumin in the 4,937 Type 2 Diabetic Subjects Recruited for the DIABHYCAR Study in Western Europe and North Africa
44. Efficacy of Diuretics and β-Blockers in Diabetic Hypertensive Patients: Results from a meta-analysis
45. Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening
46. OUTCOME OF ATRIAL FIBRILLATION AFTER MITRAL VALVE REPAIR
47. Pooling, meta-analysis, and the evaluation of drug safety
48. The Non–Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) Study: Design, Organization, and Patient Recruitment
49. Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry
50. Management of adolescents with very poorly controlled type 1 diabetes by nurses: a parallel group randomized controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.